Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Making early cerebral palsy screening more accessible

July 1, 2026
Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.
Read Transcript

The challenge

Cerebral palsy (CP) is the most common childhood-onset physical disability, affecting around 1 in 700 children born in Australia. Early diagnosis is critical, as the first months of life are a crucial period for brain development, and early intervention can improve long-term outcomes for children with CP.

Despite reliable screening tools being available, only around 30% of infants who will go on to receive a CP diagnosis are currently screened. This means many children miss the opportunity for early identification and intervention.

The General Movements Assessment (GMA) is a reliable tool for identifying babies who may be at higher risk of CP. However, limited numbers of trained assessors make it difficult to offer screening more widely. The Early General Movements Screening Feasibility Pilot is testing whether training additional assessors can help expand access to screening.

“Families should not need luck, persistence or privilege to find answers. A national screening system would help ensure they no longer do.”

Parent partner involved in the project

The research

Led by Cerebral Palsy Alliance researchers Dr Catherine Morgan, Dr Cathryn Crowle and Dr Michelle Jackman, the pilot is investigating whether newly trained assessors can complete the GMA as accurately as experienced assessors. Families are invited to record videos of their babies using the Baby Moves smartphone app, which are assessed by both newly trained and experienced assessors. Early results are encouraging, with 89% agreement between assessors, showing the potential of trained assessors to help expand access to early CP screening.

Early impact

Funding from Hearts & Minds has enabled a dedicated project coordinator and research nurses at participating hospitals to manage the study, engage families, and support infant screening across each site. This has helped ensure the pilot can be delivered effectively and families are supported throughout the screening process.

Already, 5 of the 142 babies who would not otherwise have received general movements screening have been identified as requiring follow-up, highlighting the benefit of expanding access to earlier screening.

The pilot has also helped secure additional government funding to advance universal screening using machine learning, with data from this study contributing to future research. If successful, this research could pave the way for universal CP screening across Australia, enabling more babies to receive earlier diagnosis, earlier intervention, and better long-term outcomes.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

The challenge

Cerebral palsy (CP) is the most common childhood-onset physical disability, affecting around 1 in 700 children born in Australia. Early diagnosis is critical, as the first months of life are a crucial period for brain development, and early intervention can improve long-term outcomes for children with CP.

Despite reliable screening tools being available, only around 30% of infants who will go on to receive a CP diagnosis are currently screened. This means many children miss the opportunity for early identification and intervention.

The General Movements Assessment (GMA) is a reliable tool for identifying babies who may be at higher risk of CP. However, limited numbers of trained assessors make it difficult to offer screening more widely. The Early General Movements Screening Feasibility Pilot is testing whether training additional assessors can help expand access to screening.

“Families should not need luck, persistence or privilege to find answers. A national screening system would help ensure they no longer do.”

Parent partner involved in the project

The research

Led by Cerebral Palsy Alliance researchers Dr Catherine Morgan, Dr Cathryn Crowle and Dr Michelle Jackman, the pilot is investigating whether newly trained assessors can complete the GMA as accurately as experienced assessors. Families are invited to record videos of their babies using the Baby Moves smartphone app, which are assessed by both newly trained and experienced assessors. Early results are encouraging, with 89% agreement between assessors, showing the potential of trained assessors to help expand access to early CP screening.

Early impact

Funding from Hearts & Minds has enabled a dedicated project coordinator and research nurses at participating hospitals to manage the study, engage families, and support infant screening across each site. This has helped ensure the pilot can be delivered effectively and families are supported throughout the screening process.

Already, 5 of the 142 babies who would not otherwise have received general movements screening have been identified as requiring follow-up, highlighting the benefit of expanding access to earlier screening.

The pilot has also helped secure additional government funding to advance universal screening using machine learning, with data from this study contributing to future research. If successful, this research could pave the way for universal CP screening across Australia, enabling more babies to receive earlier diagnosis, earlier intervention, and better long-term outcomes.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Read More
Picture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHI
July 1, 2026

Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.

Read More
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI
July 1, 2026

Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.

Read More
July 1, 2026

A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

Read More
Picture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthur
July 1, 2026

Closing the gap in rare disease diagnosis for Australian families

Building better genomic tools and more representative data to help families receive answers sooner.

Read More
PICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her team
July 1, 2026

Developing a new mRNA vaccine for Alzheimer’s disease

Using innovative technology to explore new possibilities for treatment and prevention.

Read More
Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS.
July 1, 2026

Unlocking new approaches for Multiple Sclerosis

Understanding why the brain fails to repair itself and exploring new treatment possibilities.

Read More
July 1, 2026

Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.

Read More
July 1, 2026

Protecting vulnerable children, when it matters most

How the Safer Kids Project is helping identify and protect children at risk in emergency care

Read More